Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
top of page
BPIQ Blog
Aug 19, 20221 min read
Free Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Jun 8, 20222 min read
Biopharma Daily Stock Updates - 06/08/22
$XBI $73.21 | +0.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA +2.2% Moderna Announces...
Jun 8, 20222 min read
Free Biopharma Daily Stock Updates - 06/08/22
$XBI $73.21 | +0.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA +2.2% Moderna Announces...
Jun 7, 20222 min read
Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 7, 20222 min read
Free Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 30, 20214 min read
CVM's Multikine readout: Why did the market react so negatively?
Summary: CVM reported its long-awaited Phase 3 results from its head & neck cancer trial for its immuno-therapy agent, Multikine, on June...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page